|
UBAP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.36439773210395E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.84169998643335E-09 |
| Normal-vs-Stage2 |
4.77119999953146E-07 |
| Normal-vs-Stage3 |
2.02690000339345E-08 |
| Normal-vs-Stage4 |
6.48630000044115E-07 |
| Stage1-vs-Stage2 |
1.659780E-01 |
| Stage1-vs-Stage3 |
3.709600E-01 |
| Stage1-vs-Stage4 |
5.064800E-01 |
| Stage2-vs-Stage3 |
5.191800E-01 |
| Stage2-vs-Stage4 |
5.388000E-01 |
| Stage3-vs-Stage4 |
9.793600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.12630005322245E-09 |
| Normal-vs-AfricanAmerican |
1.431620E-02 |
| Normal-vs-Asian |
6.42789999999449E-05 |
| Caucasian-vs-AfricanAmerican |
2.310000E-01 |
| Caucasian-vs-Asian |
7.107200E-01 |
| AfricanAmerican-vs-Asian |
4.285000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.27969998434219E-09 |
| Normal-vs-Female |
4.54539961225464E-10 |
| Male-vs-Female |
4.235200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.75800000007587E-07 |
| Normal-vs-Age(41-60Yrs) |
5.94399973685711E-10 |
| Normal-vs-Age(61-80Yrs) |
1.09960041072554E-10 |
| Normal-vs-Age(81-100Yrs) |
2.216400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.316600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.094110E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.828800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.081900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.234800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.795400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.535000E-01 |
| Classical-VS-Follicular |
1.22269999680569E-08 |
| Classical-VS-Other |
2.617200E-01 |
| Classical-VS-Normal |
2.06259999999681E-05 |
| Tall-VS-Follicular |
6.077500E-03 |
| Tall-VS-Other |
4.418600E-01 |
| Tall-VS-Normal |
4.233200E-04 |
| Follicular-VS-Other |
4.649200E-01 |
| Follicular-VS-Normal |
1.91946458727443E-12 |
| Other-VS-Normal |
1.002040E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.83000281595014E-11 |
| Normal-vs-N1 |
1.20240000001104E-06 |
| N0-vs-N1 |
7.470600E-01 |
|
|
